The Biology Team at Dunad Therapeutics conducts cutting-edge research to identify and validate therapeutic targets for next-generation oral protein degradation therapies. They are responsible for developing and optimizing biological assays, characterizing the molecular mechanisms of target degradation, and evaluating the efficacy and specificity of tunable mono-valent small molecules in preclinical models.
View all